Jump to navigation
The latest clinical and political news for Australian Rheumatologists
But there's five pathological causes to watch for, experts say.
The interleukin-17A inhibitor also benefited the joints.
In the first year the effects differ depending on the agent.
Study shows women on TNF alpha inhibitors are at no increased risk.
You might be surprised.
Large study compares the effect with patients on allopurinol.
Some proceduralists' risks rival that of labourers, a meta-analysis shows.
The country is out on a limb.
It's a more common comorbidity than you think.
Study fails to back off-label use.
Diabetes and osteoarthritis; TNF inhibitors in kids; Ankylosing spondylitis.
There may be a narrow window of opportunity for complete remission.
First RA brain-imaging studies suggest it does
Information and empathy are important to patients
Affected patients with early systemic sclerosis need multi-disciplinary care, researchers say.
JIA in pregnancy | Bones and ankylosing spondylitis | Leflunomide and birth defects
Internet discussion site reveals poor grasp of aetiology and management strategies.
Snapshot from real-world data on treatment duration in rheumatoid arthritis.
It's not just about the ageing population, specialists say.
ACCC says legal case resembles $6 milllion action on Nurofen specific branding.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.